National Center for Advancing Translational Sciences; Notice of Meetings, 15526-15527 [2017-06148]
Download as PDF
15526
Federal Register / Vol. 82, No. 59 / Wednesday, March 29, 2017 / Notices
Date: April 21, 2017.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
Contact Person: Xiang-Ning Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, 301–435–
1744, lixiang@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 23, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06147 Filed 3–28–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information for the
Development of the Fiscal Year 2019
Trans-NIH Plan for HIV-Related
Research
Through this Request for
Information (RFI), the Office of AIDS
Research (OAR) in the Division of
Program Coordination, Planning, and
Strategic Initiatives (DPCPSI), National
Institutes of Health (NIH), invites
feedback from investigators in
academia, industry, health care
professionals, patient advocates and
health advocacy organizations, scientific
or professional organizations, federal
agencies, community, and other
interested constituents on the
development of the fiscal year (FY) 2019
Trans-NIH Plan for HIV-Related
Research (FY 2019 AIDS Research Plan).
This plan is designed to identify and
articulate future directions to maximize
the NIH’s investments in HIV/AIDS
research.
DATES: The OAR’s Request for
Information is open for public comment
for a period of 45 days. Comments must
be received by May 15, 2017 to ensure
consideration. After the public comment
period has closed, the comments
received by the OAR will be considered
in a timely manner for the development
of the FY2019 AIDS Research Plan.
ADDRESSES: Submissions may be
electronically sent to https://
grants.nih.gov/grants/rfi/rfi.cfm?ID=63
or, if needed, by mail to Paul Gaist,
Ph.D., M.P.H. Office of AIDS Research,
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:54 Mar 28, 2017
Jkt 241001
National Institutes of Health, Room
2E40, 5601 Fishers Lane, Rockville,
Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Questions about this request for
information should be directed to Paul
Gaist, Ph.D., M.P.H. Office of AIDS
Research, National Institutes of Health
Email: ODOARRFI19@nih.gov or if
needed, by mail to Room 2E40, 5601
Fishers Lane, Rockville, Maryland
20852.
This RFI is for planning purposes
only and should not be construed as a
solicitation for applications or
proposals, or as an obligation in any
way on the part of the United States
federal government. The federal
government will not pay for the
preparation of any information
submitted or for the government’s use.
Additionally, the government cannot
guarantee the confidentiality of the
information provided.
To access
and respond to the RFI, go to the
following Web address: https://grants.
nih.gov/grants/rfi/rfi.cfm?ID=63.
OAR oversees and coordinates the
conduct and support of all HIV/AIDS
research activities across the NIH
Institutes and Centers (ICs). The NIHsponsored HIV/AIDS research program
includes both extramural and
intramural research, buildings and
facilities, research training, program
evaluation, and supports a
comprehensive portfolio of research
representing a broad range of basic,
clinical, behavioral, social science, and
translational research on HIV/AIDS and
its associated coinfections and
comorbidities.
OAR plans and coordinates research
through the development of an annual
Trans-NIH Plan for HIV-Related
Research that articulates the overarching
HIV/AIDS research priorities and serves
as the framework for developing the
trans-NIH HIV/AIDS research budget.
This Plan provides information about
the NIH’s HIV/AIDS research priorities
to the scientific community, Congress,
community stakeholders, HIV-affected
communities, and the broad public at
large. The fiscal year 2018 Trans-NIH
Plan for HIV-Related Research was
recently distributed on the OAR Web
site: (https://www.oar.nih.gov/strategic_
plan/plan_18.asp).
New overarching priorities for HIV/
AIDS research were defined in the NIH
Director’s Statement of August 12, 2015
(https://grants.nih.gov/grants/guide/
notice-files/NOT-OD-15-137.html).
High Priority topics of research for
support include:
(1) Reducing the incidence of HIV/
AIDS;
(2) Developing the next generation of
HIV therapies;
(3) Identifying strategies towards a
cure;
(4) Improving the prevention and
treatment of HIV-associated
comorbidities, coinfections, and
complications; and
(5) Cross-cutting basic research,
behavioral and social science research,
health disparities, and training.
Dated: March 23, 2017.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
[FR Doc. 2017–06183 Filed 3–28–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Center for Advancing Translational
Sciences.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cures Acceleration
Network Review Board.
Date: May 4, 2017.
Time: 8:30 a.m. to 2:30 p.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
E:\FR\FM\29MRN1.SGM
29MRN1
Federal Register / Vol. 82, No. 59 / Wednesday, March 29, 2017 / Notices
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: May 4, 2017.
Open: 8:30 a.m. to 2:30 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Closed: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, Md
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: March 23, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06148 Filed 3–28–17; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Institute of
Neurological Disorder and Stroke; Special
Emphasis Panel, Clinical Trials in Stroke.
Date: April 18, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
435–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorder and Stroke; Special
Emphasis Panel, Loan Repayment Program
2017.
Date: April 28, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Ernest Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–4056, lyonse@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: March 23, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06149 Filed 3–28–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
mstockstill on DSK3G9T082PROD with NOTICES
National Institutes of Health
Substance Abuse and Mental Health
Services Administration
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
16:54 Mar 28, 2017
Jkt 241001
Center for Substance Abuse
Treatment; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA’s)
Center for Substance Abuse Treatment
(CSAT) National Advisory Council will
meet on April 12, 2017, 3:00 p.m.–4:00
p.m. (EDT) in a closed teleconference
meeting.
The meeting will include discussions
and evaluations of grant applications
reviewed by SAMHSA’s Initial Review
Groups, and involve an examination of
confidential financial and business
information as well as personal
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
15527
information concerning the applicants.
Therefore, the meeting will be closed to
the public as determined by the
SAMHSA Acting Deputy Assistant
Secretary for Mental Health and
Substance Use in accordance with 5
U.S.C. 552b(c)(4) and (6) and 5 U.S.C.
App. 2, 10(d).
Meeting information and a roster of
Council members may be obtained by
accessing the SAMHSA Committee Web
site at https://www.samhsa.gov/about-us/
advisory-councils/csat-nationaladvisory-council or by contacting the
CSAT National Advisory Council
Designated Federal Officer, Tracy Goss
(see contact information below).
Council Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: April 12, 2017, 3:00
p.m.–4:00 p.m. EDT, CLOSED.
Place: SAMHSA, 5600 Fishers Lane,
Rockville, Maryland 20857.
Contact: Tracy Goss, Designated
Federal Officer, CSAT National
Advisory Council, 5600 Fishers Lane,
Rockville, Maryland 20857 (mail),
Telephone: (240) 276–0759, Fax: (240)
276–2252, Email: tracy.goss@
samhsa.hhs.gov.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2017–06168 Filed 3–28–17; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
E:\FR\FM\29MRN1.SGM
29MRN1
Agencies
[Federal Register Volume 82, Number 59 (Wednesday, March 29, 2017)]
[Notices]
[Pages 15526-15527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06148]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
National Center for Advancing Translational Sciences.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Cures Acceleration Network Review Board.
Date: May 4, 2017.
Time: 8:30 a.m. to 2:30 p.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health, Building 31, Conference
Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive
Secretary, National Center for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809,
anna.ramseyewing@nih.gov.
[[Page 15527]]
Name of Committee: National Center for Advancing Translational
Sciences Advisory Council.
Date: May 4, 2017.
Open: 8:30 a.m. to 2:30 p.m.
Agenda: Report from the Institute Director and other staff.
Place: National Institutes of Health, Building 31, Conference
Room 6, 31 Center Drive, Bethesda, MD 20892.
Closed: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, Conference
Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive
Secretary, National Center for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, Md 20892, 301-435-0809,
anna.ramseyewing@nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: March 23, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06148 Filed 3-28-17; 8:45 am]
BILLING CODE 4140-01-P